Picture of Scancell Holdings logo

SCLP — Scancell Holdings Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Scancell Holdings, fiscal year end - April 30th, GBP millions except per share, conversion factor applied.

2022
April 30th
2023
April 30th
2024
April 30th
2025
April 30th
2026
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalPreliminary
Net Income/Starting Line-3.77-14.3-9.12-15.3-20.2
Depreciation
Non-Cash Items-8.843.11-8.531.694.61
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.682.151.026.344.17
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-10.2-8.14-15.7-6.4-10.8
Capital Expenditures-1.27-0.203-0.177-1.54-0.094
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0040.2840.3550.3360.75
Other Investing Cash Flow
Cash from Investing Activities-1.260.0810.178-1.20.656
Financing Cash Flow Items-0.537-0.537-1.24-0.741-0.076
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.928-0.74610.49.69-1.43
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-12.4-8.8-5.12.08-11.6